Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Gedeon Richter have reached an exclusive commercialization and license agreement for BAT2206, a biosimilar candidate to Stelara, it was announced on the website of the Budapest Stock Exchange. Under the agreement, Bio-Thera will maintain responsibility for development, manufacturing, and supply […]